cbdMD (YCBD) Restructuring Costs (2022)

cbdMD's (YCBD) quarterly Restructuring Costs came in at $602092.0 in Q2 2022.

cbdMD (YCBD) Restructuring Costs (2022) Analysis & Trends

cbdMD has disclosed Restructuring Costs across 1 years of filings, most recently posting $602092.0 for Q2 2022.

Restructuring Costs for Q2 2022 came in at $602092.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2023 was $602092.0 (changed 0.0% YoY), and the FY2022 annual result was $602092.0, changed N/A from the prior year.
Restructuring Costs came in at $602092.0 for Q2 2022 at cbdMD.
In the past five years, Restructuring Costs ranged from a high of $602092.0 in Q2 2022 to a low of $602092.0 in Q2 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn
10	cbdMD	3,905.91	-3.38 Mn	3.00 Mn

Historic Data

Download Data

Date	Value
Jun 30, 2022	602,092.00